bullish vs bearish | atai life sciences | psychedelic invest
Published 1 year ago • 1.4K plays • Length 43:38Download video MP4
Download video MP3
Similar videos
-
26:21
florian brand (atai life sciences): psychedelics – the new psychiatric frontier | slush 2021
-
21:29
pro: atai life sciences $atai earnings report breakdown | analysis | psychedelic invest
-
14:58
investing in psychedelics with atai life sciences | presented by cse and cfn media
-
3:59
atai life sciences founder on using psychedelics to treat mental illness
-
16:01
atai earnings report | psychedelic invest deep dive | march 30, 2022
-
8:45
feeling amanita vs benefits of the medicine
-
46:28
atai life sciences: psychedelics, mental health, & drug development w/ founder christian angermayer
-
6:51
i tried microdosing psychedelics for 30 days and here's what happened
-
11:55
new nasdaq psychedelic stock is an ip giant | atai life sciences
-
11:56
atai life sciences 'bringing innovation to mental healthcare and treatment addiction'
-
25:46
psychedelic leader reports earnings | ceo florian brand - atai life sciences
-
11:30
atai life sciences' plan to boost shareholder value and field trip's fight against bankruptcy
-
34:00
pro: "the big 3" | $atai, $mnmd, $cmps post q1 2022 er and pipeline comparison | psychedelic invest
-
10:14
my prediction for psychedelic medicines | christian angermayer | atai life sciences | mindmed
-
11:20
weekly extractions | mindmed, compass pathways, atai, and bright minds | psychedelic invest
-
8:54
psychedelics might change mental healthcare. will investors follow?
-
0:05
the stock of psychedelics giant atai is tumbling after a treatment failed to help patients |#shorts
-
16:06
weekly extractions | atai's kur-101 and pcn - 101 trial results | psychedelic invest
-
1:01
$psyc highlights featuring atai life sciences
-
0:05
the stock of psychedelics giant atai is tumbling after a treatment failed to help patients |#shorts
-
7:07
atai life sciences outlines key milestones in psychedelic therapy for depression in 2023 and 2024
-
8:50
atai life sciences: clear leader in psychedelics has huge upside